Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

Question 2

How does bapineuzumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my visits and treatments look like during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) clinical trial (NCT00575055). Contact the study team or your healthcare provider for specific answers.

What this study is about